146 related articles for article (PubMed ID: 8729129)
1. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
2. Renal allograft platelet activating factor synthesis during acute cellular rejection.
Mangino MJ; Anderson CB; Murphy MK; Turk J
J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor in human normal tears.
Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
Almer S; Kald B; Franzén L; Ström M; Tagesson C
Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
8. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells.
Hichami A; Duroudier V; Leblais V; Vernhet L; Le Goffic F; Ninio E; Legrand A
Eur J Biochem; 1997 Dec; 250(2):242-8. PubMed ID: 9428670
[TBL] [Abstract][Full Text] [Related]
9. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor acetylhydrolases in Caco-2 cells and epithelium of normal and ulcerative colitis patients.
Riehl TE; Stenson WF
Gastroenterology; 1995 Dec; 109(6):1826-34. PubMed ID: 7498647
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis.
Rachmilewitz D; Karmeli F; Eliakim R
Scand J Gastroenterol Suppl; 1990; 172():19-21. PubMed ID: 1972295
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Eliakim R; Karmeli F; Razin E; Rachmilewitz D
Gastroenterology; 1988 Nov; 95(5):1167-72. PubMed ID: 2901995
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Rachmilewitz D; Eliakim R; Simon P; Ligumsky M; Karmeli F
Agents Actions; 1992; Spec No():C32-6. PubMed ID: 1359744
[TBL] [Abstract][Full Text] [Related]
14. Intraluminal excretion of PAF, lysoPAF, and acetylhydrolase in patients with ulcerative colitis.
Guimbaud R; Izzo A; Martinolle JP; Vidon N; Couturier D; Benveniste J; Chaussade S
Dig Dis Sci; 1995 Dec; 40(12):2635-40. PubMed ID: 8536524
[TBL] [Abstract][Full Text] [Related]
15. Catabolism of platelet-activating factor by human colonic mucosa. Calcium dependence of the catabolizing enzymes.
Appleyard CB; Hillier K
Biochem Pharmacol; 1992 Jun; 43(12):2503-9. PubMed ID: 1632809
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
[TBL] [Abstract][Full Text] [Related]
18. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Haroldsen PE; Clay KL; Murphy RC
J Lipid Res; 1987 Jan; 28(1):42-9. PubMed ID: 3104521
[TBL] [Abstract][Full Text] [Related]
20. Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion.
Wardle TD; Hall L; Turnberg LA
Gut; 1996 Mar; 38(3):355-61. PubMed ID: 8675086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]